[1]
|
NUCLEOTIDE SEQUENCE [MRNA].
Cui W.C.,
Yu L.,
Chu Y.Y.,
Wang J.,
Zheng L.H.,
Zhou G.J.,
Zhao S.Y.;
Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
|
[2]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Brain;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[3]
|
NUCLEOTIDE SEQUENCE [MRNA] OF 1-318.
TISSUE=Brain;
PubMed=3755548 [NCBI, ExPASy, EBI, Israel, Japan]
Coussens L.,
Parker P.J.,
Rhee L.,
Yang-Feng T.L.,
Chen E.,
Waterfield M.D.,
Francke U.,
Ullrich A.;
"Multiple, distinct forms of bovine and human protein kinase C suggest diversity in cellular signaling pathways.";
Science 233:859-866(1986).
|
[4]
|
NUCLEOTIDE SEQUENCE [MRNA] OF 162-697.
TISSUE=Hippocampus;
PubMed=8375396 [NCBI, ExPASy, EBI, Israel, Japan]
Kochs G.,
Hummel R.,
Meyer D.,
Hug H.,
Marme D.,
Sarre T.F.;
"Activation and substrate specificity of the human protein kinase C alpha and zeta isoenzymes.";
Eur. J. Biochem. 216:597-606(1993).
|
[5]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-195, AND MASS SPECTROMETRY.
DOI=10.1016/j.cell.2007.11.025; PubMed=18083107 [NCBI, ExPASy, EBI, Israel, Japan]
Rikova K.,
Guo A.,
Zeng Q.,
Possemato A.,
Yu J.,
Haack H.,
Nardone J.,
Lee K.,
Reeves C.,
Li Y.,
Hu Y.,
Tan Z.,
Stokes M.,
Sullivan L.,
Mitchell J.,
Wetzel R.,
Macneill J.,
Ren J.M.,
Yuan J., ![]()
Bakalarski C.E.,
Villen J.,
Kornhauser J.M.,
Smith B.,
Li D.,
Zhou X.,
Gygi S.P.,
Gu T.-L.,
Polakiewicz R.D.,
Rush J.,
Comb M.J.;
"Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.";
Cell 131:1190-1203(2007).
|
[6]
|
VARIANTS CYS-141; GLN-415; ASP-523 AND SER-659.
DOI=10.1086/301819; PubMed=9545390 [NCBI, ExPASy, EBI, Israel, Japan]
Al-Maghtheh M.,
Vithana E.N.,
Inglehearn C.F.,
Moore T.,
Bird A.C.,
Bhattacharya S.S.;
"Segregation of a PRKCG mutation in two RP11 families.";
Am. J. Hum. Genet. 62:1248-1252(1998).
|
[7]
|
SHOWS THAT THE VARIANTS ARE NOT A CAUSE OF RP11.
DOI=10.1086/302554; PubMed=10441600 [NCBI, ExPASy, EBI, Israel, Japan]
Dryja T.P.,
McEvoy J.,
McGee T.L.,
Berson E.L.;
"No mutations in the coding region of the PRKCG gene in three families with retinitis pigmentosa linked to the RP11 locus on chromosome 19q.";
Am. J. Hum. Genet. 65:926-928(1999).
|
[8]
|
VARIANTS SCA14 TYR-101; PRO-119 AND ASP-128.
DOI=10.1086/373883; PubMed=12644968 [NCBI, ExPASy, EBI, Israel, Japan]
Chen D.-H.,
Brkanac Z.,
Verlinde C.L.M.J.,
Tan X.-J.,
Bylenok L.,
Nochlin D.,
Matsushita M.,
Lipe H.,
Wolff J.,
Fernandez M.,
Cimino P.J.,
Bird T.D.,
Raskind W.H.;
"Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia.";
Am. J. Hum. Genet. 72:839-849(2003).
|
[9]
|
INTERACTION WITH CDCP1.
DOI=10.1016/j.cell.2005.02.019; PubMed=15851033 [NCBI, ExPASy, EBI, Israel, Japan]
Benes C.H.,
Wu N.,
Elia A.E.H.,
Dharia T.,
Cantley L.C.,
Soltoff S.P.;
"The C2 domain of PKCdelta is a phosphotyrosine binding domain.";
Cell 121:271-280(2005).
|
|
ExPASy Home page
SIB Switzerland
